Navigation Links
Kenya halts first field trials of GM maize

Kenyan authorities began destroying the country's first genetically modified (GM) maize growing in open field trials.

The government halted the research and ordered the destruction after discovering that a technician had sprayed a restricted pesticide on maize modified to resist attack by insects called stem borers.

Wilson Songa, Kenya's agriculture secretary and chair of the National Biosafety Committee, said this could compromise the validity of the trial's results.

On 25 August, the committee ordered the Kenya Plant Health Inspectorate Service to destroy the crops.

Songa was quoted in Kenya's Sunday Nation newspaper on 28 August as saying that local scientists had yielded to pressure from international organisations and were "rushing projects".

The maize was being grown in Kiboko by the Insect Resistance Maize for Africa (IRMA) project, a joint initiative of the Kenyan Agricultural Research Institute, the US-based Syngenta foundation, and the Mexico-based Center for Maize and Wheat Research.

In July, IRMA staff had notified the biosafety committee that the maize had been sprayed with the insecticide Furadan.

Stephen Mugo, IRMA's project coordinator, says the incident was unfortunate and a major setback to Kenyan research, but that GM maize field trials would continue.

"This is just like a battle we lost," said Mugo. "But the main war will continue until we help African maize farmers overcome the pest".

Stem borers destroy up to 12 per cent of maize growing in Kenya, amounting to US$76 million in lost harvests per year.

The IRMA project, which began six years ago, aims to develop both conventional and GM maize varieties to resist the pest.

The GM plants, which incorporate genetic material from a bacterium called Bacillus thuringiensis, have already been grown under experimental conditions in IRMA's US$12 million 'biosafety' greenhouse (see $12 million greenhouse signals Kenyan GM commitment).

When the first IRMA maize seeds were sown outside in May, Kenya became the first African country after South Africa to plant GM maize in open fields (see Kenya begins first open field trials of GM maize).
The IRMA researchers had hoped to release the maize to farmers by 2010 (see Revision of plans delays Kenya's GM maize).


'"/>

Source:SciDev.Net


Related biology news :

1. Intrinsic eye protein halts angiogenesis
2. Trojan Horse agent halts bone metastasis in mice
3. A genes first kiss sets off that affair known as puberty
4. Love at first smell
5. Worlds largest rainforest drying experiment completes first phase
6. PCRM develops worlds first cruelty-free insulin assay
7. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
8. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
9. DuPonts first biologically derived polymer receives global recognition
10. Anti cancer virotherapy well tolerated in first human administration, research finds
11. Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
Breaking Biology Technology: